2-((2-Oxo-2-((2-Oxotetrahydrothiophen-3-Yl)Amino)Ethyl)Thio)Acetic Acid 2-((2-氧代-2-((2-氧代四氢噻吩-3-基)氨基)乙基)硫基)乙酸
CAS 84611-23-4 MFCD00867664
化学结构图
SMILES: OC(=O)CSCC(=O)NC1CCSC1=O
化学属性
| Mol. Formula | C8H11NO4S2 |
|---|---|
| Mol. Weight | 249.30 |
| Melting Point | 160.0 to 164.0 deg-C |
别名和识别编码
| Chemical Name | 2-((2-Oxo-2-((2-Oxotetrahydrothiophen-3-Yl)Amino)Ethyl)Thio)Acetic Acid |
|---|---|
| CAS Number | 84611-23-4 |
| Synonym | Erdosteine Dithiosteine RV 144 ((2-Oxo-2-((tetrahydro-2-oxo-3-thienyl)amino)ethyl)thio)acetic acid 2-[[2-Oxo-2-[(tetrahydro-2-oxo-3-thienyl)amino]ethyl]thio]acetic Acid DL-S-(2-(N-3-(2-Oxotetrahydrotheinyl)acetamido))thioglycolic acid PV 144 Acide ((2-oxo-3-tetrahydrothienylcarbamoyl)-methylthio)acetique |
| Chemical Name Translation | 2-((2-氧代-2-((2-氧代四氢噻吩-3-基)氨基)乙基)硫基)乙酸 |
| Reaxys-RN | 6972806 |
| MDL Number | MFCD00867664 |
| PubChem Substance ID | 253661978 |
| Merck Number | 3647 |
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Heterocycles
- Pharmaceuticals
- Intermediates & Fine Chemicals
- Sulfur & Selenium Compounds
产品应用
- Erdosteine is a mucolytic. Erdosteine was developed for the treatment of chronic obstructive bronchitis.
相关文献及参考
- Kuvandik, G., et al.: Toxicol. Pathol., 36, 714 (2008),
安全信息
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - rat DOSE/DURATION : >10 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0061386
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >10 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0061386
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >3500 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : DECRDP Drugs under Experimental and Clinical Research. (Bioscience Ediprint, Blvd. James-Fazy 13, 1201 Geneva 1, Switzerland) V.1- 1977- Volume(issue)/page/year: 14,693,1988
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - rat DOSE/DURATION : >3500 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : EPXXDW European Patent Application. (U.S. Patent and Trademark Office, Foreign Patents, Washington, DC 20231) Volume(issue)/page/year: #0061386
京ICP备2020036287号